VOVLHKYHRNGMRZ-KYJIQIAGSA-N
C26H29F3N2O11 — CID 122671477
Data last refreshed: (MolForge compound catalog, from PubChem)
About VOVLHKYHRNGMRZ-KYJIQIAGSA-N
VOVLHKYHRNGMRZ-KYJIQIAGSA-N (PubChem CID 122671477) has the molecular formula C26H29F3N2O11 and a molecular weight of 602.52 g/mol. Its IUPAC name is (2S)-4-[[3-[[(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]oxy]-3-oxopropyl]amino]-2-hydroxy-4-oxobutanoic acid;2,2,2-trifluoroacetic acid.
Molecular Properties
| Compound Name | VOVLHKYHRNGMRZ-KYJIQIAGSA-N |
|---|---|
| PubChem CID | 122671477 |
| Molecular Formula | C26H29F3N2O11 |
| Molecular Weight | 602.52 g/mol |
| Exact Mass | 602.17 |
| IUPAC Name | (2S)-4-[[3-[[(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]oxy]-3-oxopropyl]amino]-2-hydroxy-4-oxobutanoic acid;2,2,2-trifluoroacetic acid |
| SMILES | CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(OC(=O)CCNC(=O)C[C@H](O)C(=O)O)=CC[C@@]3(O)[C@H]1C5.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C24H28N2O9.C2HF3O2/c1-26-9-7-23-19-12-2-3-13(27)20(19)35-21(23)15(4-6-24(23,33)16(26)10-12)34-18(30)5-8-25-17(29)11-14(28)22(31)32;3-2(4,5)1(6)7/h2-4,14,16,21,27-28,33H,5-11H2,1H3,(H,25,29)(H,31,32);(H,6,7)/t14-,16+,21-,23-,24+;/m0./s1 |
| InChIKey | VOVLHKYHRNGMRZ-KYJIQIAGSA-N |
| XLogP | 0.19 |
| TPSA | 203.16 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 602.52 |
| LogP ≤ 5 | 0.19 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122671477 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.